These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
413 related articles for article (PubMed ID: 27029920)
1. CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial. Tong SY; Nelson J; Paterson DL; Fowler VG; Howden BP; Cheng AC; Chatfield M; Lipman J; Van Hal S; O'Sullivan M; Robinson JO; Yahav D; Lye D; Davis JS; Trials; 2016 Mar; 17():170. PubMed ID: 27029920 [TBL] [Abstract][Full Text] [Related]
2. Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial. Tong SYC; Lye DC; Yahav D; Sud A; Robinson JO; Nelson J; Archuleta S; Roberts MA; Cass A; Paterson DL; Foo H; Paul M; Guy SD; Tramontana AR; Walls GB; McBride S; Bak N; Ghosh N; Rogers BA; Ralph AP; Davies J; Ferguson PE; Dotel R; McKew GL; Gray TJ; Holmes NE; Smith S; Warner MS; Kalimuddin S; Young BE; Runnegar N; Andresen DN; Anagnostou NA; Johnson SA; Chatfield MD; Cheng AC; Fowler VG; Howden BP; Meagher N; Price DJ; van Hal SJ; O'Sullivan MVN; Davis JS; JAMA; 2020 Feb; 323(6):527-537. PubMed ID: 32044943 [TBL] [Abstract][Full Text] [Related]
3. What do beta-lactams add to vancomycin or daptomycin in the treatment of patients with methicillin-resistant García Aragonés L; Blanch Sancho JJ; Segura Luque JC; Mateos Rodriguez F; Martínez Alfaro E; Solís García Del Pozo J Postgrad Med J; 2022 Jan; 98(1155):48-56. PubMed ID: 33563707 [TBL] [Abstract][Full Text] [Related]
5. Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant Yi YH; Wang JL; Yin WJ; Xu WH Microb Drug Resist; 2021 Aug; 27(8):1044-1056. PubMed ID: 33728980 [No Abstract] [Full Text] [Related]
6. Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial. Cheng MP; Lawandi A; Butler-Laporte G; Paquette K; Lee TC Trials; 2018 May; 19(1):297. PubMed ID: 29843781 [TBL] [Abstract][Full Text] [Related]
7. Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial. Legg A; Meagher N; Johnson SA; Roberts MA; Cass A; Scheetz MH; Davies J; Roberts JA; Davis JS; Tong SYC Clin Drug Investig; 2023 Jan; 43(1):23-33. PubMed ID: 36217068 [TBL] [Abstract][Full Text] [Related]
8. Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates. Rehm SJ; Boucher H; Levine D; Campion M; Eisenstein BI; Vigliani GA; Corey GR; Abrutyn E J Antimicrob Chemother; 2008 Dec; 62(6):1413-21. PubMed ID: 18782781 [TBL] [Abstract][Full Text] [Related]
9. A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study. Kalimuddin S; Chan YFZ; Phillips R; Ong SP; Archuleta S; Lye DC; Tan TT; Low JGH Trials; 2018 Jun; 19(1):305. PubMed ID: 29859132 [TBL] [Abstract][Full Text] [Related]
10. Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial. Davis JS; Sud A; O'Sullivan MVN; Robinson JO; Ferguson PE; Foo H; van Hal SJ; Ralph AP; Howden BP; Binks PM; Kirby A; Tong SYC; ; ; Tong S; Davis J; Binks P; Majumdar S; Ralph A; Baird R; Gordon C; Jeremiah C; Leung G; Brischetto A; Crowe A; Dakh F; Whykes K; Kirkwood M; Sud A; Menon M; Somerville L; Subedi S; Owen S; O'Sullivan M; Liu E; Zhou F; Robinson O; Coombs G; Ferguson P; Ralph A; Liu E; Pollet S; Van Hal S; Foo H; Van Hal S; Davis R Clin Infect Dis; 2016 Jan; 62(2):173-180. PubMed ID: 26349552 [TBL] [Abstract][Full Text] [Related]
11. Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial. Shaw E; Miró JM; Puig-Asensio M; Pigrau C; Barcenilla F; Murillas J; Garcia-Pardo G; Espejo E; Padilla B; Garcia-Reyne A; Pasquau J; Rodriguez-Baño J; López-Contreras J; Montero M; de la Calle C; Pintado V; Calbo E; Gasch O; Montejo M; Salavert M; Garcia-Pais MJ; Carratalà J; Pujol M; ; ; BMJ Open; 2015 Mar; 5(3):e006723. PubMed ID: 25762232 [TBL] [Abstract][Full Text] [Related]
12. Methicillin-resistant Staphylococcus aureus infections: role of daptomycin/β-lactams combination. Leone S; Noviello S; Boccia G; De Caro F; Esposito S Infez Med; 2015 Jun; 23(2):99-104. PubMed ID: 26110289 [TBL] [Abstract][Full Text] [Related]
13. Analysis of synergy between beta-lactams and anti-methicillin-resistant Staphylococcus aureus agents from the standpoint of strain characteristics and binding action. Ono D; Yamaguchi T; Hamada M; Sonoda S; Sato A; Aoki K; Kajiwara C; Kimura S; Fujisaki M; Tojo H; Sasaki M; Murakami H; Kato K; Ishii Y; Tateda K J Infect Chemother; 2019 Apr; 25(4):273-280. PubMed ID: 30713034 [TBL] [Abstract][Full Text] [Related]
14. Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis. Casapao AM; Jacobs DM; Bowers DR; Beyda ND; Dilworth TJ; Pharmacotherapy; 2017 Nov; 37(11):1347-1356. PubMed ID: 28949410 [TBL] [Abstract][Full Text] [Related]
15. Vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations: study protocol for a phase IIB randomized controlled trial. Kalimuddin S; Phillips R; Gandhi M; de Souza NN; Low JG; Archuleta S; Lye D; Tan TT Trials; 2014 Jun; 15():233. PubMed ID: 24943129 [TBL] [Abstract][Full Text] [Related]